![Kjetil Hestdal](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Kjetil Hestdal
Direktor/Vorstandsmitglied bei
LYTIX BIOPHARMA ASA
Profil
Kjetil Hestdal is the founder of Caedo Oncology AS, serving as Chief Executive Officer since 2020.
Current jobs include Chief Executive Officer at Serca Pharmaceuticals AS since 2018, Chairman at K & K AS since 2002, and Independent Non-Executive Director at Lytix Biopharma.
AS since 2021.
Former jobs include President & Chief Executive Officer at Photocure ASA from 2005 to 2018, Chairman at PCI Biotech Holding ASA, Senior Scientist at Rikshospitalet HF, and Project Manager at Novartis Norge AS.
Aktive Positionen von Kjetil Hestdal
| Unternehmen | Position | Beginn |
|---|---|---|
| LYTIX BIOPHARMA ASA | Direktor/Vorstandsmitglied | 07.06.2021 |
Serca Pharmaceuticals AS
 Serca Pharmaceuticals AS Pharmaceuticals: MajorHealth Technology Develops drug treatment products for injuries | Vorstandsvorsitzender | 01.11.2018 |
K & K AS
 K & K AS Miscellaneous Commercial ServicesCommercial Services Provides business and management consulting services | Vorsitzender | 27.08.2002 |
Caedo Oncology AS
 Caedo Oncology AS BiotechnologyHealth Technology Develops new strategies for monoclonal anti-body based therapy | Vorstandsvorsitzender | 28.11.2020 |
Ehemalige bekannte Positionen von Kjetil Hestdal
| Unternehmen | Position | Ende |
|---|---|---|
| PHOTOCURE ASA | Vorstandsvorsitzender | 01.07.2018 |
Rikshospitalet HF
 Rikshospitalet HF Hospital/Nursing ManagementHealth Services Operates hospitals and healthcare centers | Technik-/Wissenschafts-/F&E-Leiter | - |
Novartis Norge AS
 Novartis Norge AS Miscellaneous Commercial ServicesCommercial Services Engages in discovering, developing and marketing of drugs | Corporate Officer/Principal | - |
| PCI BIOTECH HOLDING ASA | Vorsitzender | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
54
Beziehungen ersten Grades
8
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 8 |
|---|---|
PCI Biotech Holding ASA
 PCI Biotech Holding ASA BiotechnologyHealth Technology Develops photochemical drug delivery technology for use in therapeutic treatment | Health Technology |
Photocure ASA
 Photocure ASA Medical SpecialtiesHealth Technology Develops and sells pharmaceuticals and medical devices | Health Technology |
Lytix Biopharma AS
 Lytix Biopharma AS Pharmaceuticals: MajorHealth Technology Operates as a clinical stage biotechnology company that develops novel cancer immunotherapies | Health Technology |
Rikshospitalet HF
Rikshospitalet HF Hospital/Nursing ManagementHealth Services Operates hospitals and healthcare centers | Health Services |
Novartis Norge AS
Novartis Norge AS Miscellaneous Commercial ServicesCommercial Services Engages in discovering, developing and marketing of drugs | Commercial Services |
K & K AS
K & K AS Miscellaneous Commercial ServicesCommercial Services Provides business and management consulting services | Commercial Services |
Serca Pharmaceuticals AS
Serca Pharmaceuticals AS Pharmaceuticals: MajorHealth Technology Develops drug treatment products for injuries | Health Technology |
Caedo Oncology AS
Caedo Oncology AS BiotechnologyHealth Technology Develops new strategies for monoclonal anti-body based therapy | Health Technology |
